for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

SenesTech Inc

SNES.OQ

Latest Trade

1.00USD

Change

0.04(+3.96%)

Volume

13,455

Today's Range

0.96

 - 

1.00

52 Week Range

0.55

 - 

1.95

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
0.96
Open
0.96
Volume
13,455
3M AVG Volume
4.67
Today's High
1.00
Today's Low
0.96
52 Week High
1.95
52 Week Low
0.55
Shares Out (MIL)
28.29
Market Cap (MIL)
27.16
Forward P/E
-2.67
Dividend (Yield %)
--

Latest Developments

More

Senestech Announces Second Quarter Loss Per Share $0.09

Senestech Announces Pricing Of $4.1 Million Public Offering Of Common Stock

Senestech Announces Proposed Public Offering Of Common Stock

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About SenesTech Inc

SenesTech, Inc. is a United States-based biotechnology platform and research company. The Company is engaged in developing a technology for managing animal populations by fertility control. It offers ContraPest, a fertility control product candidate. ContraPest's technology and approach targets the reproductive capabilities of both sexes. Using bait stations, ContraPest is dispensed in a palatable liquid formulation that promotes sustained consumption by rodent communities. Its formulation causes both female and male rats to become infertile once they have consumed the dose. The active ingredient in females accelerates the rate at which ovarian follicles (egg structures) are depleted. Once these cells are gone, the animal cannot reproduce. In males, there is a marked reduction in the ability to fertilize eggs and, often complete sterility. ContraPest is designed, formulated and dispensed for handlers and non-target species, such as wildlife and pets in a biodegradable product.

Industry

Chemical Manufacturing

Contact Info

3140 N Caden Ct Ste 1

+1.928.7794143

https://senestech.com/

Executive Leadership

Loretta Powers Mayer

Chairman of the Board, Chief Scientific Officer

Cheryl Ann Dyer

President, Chief Research Officer, Director

Kenneth Siegel

Chief Executive Officer, Director

Thomas C. Chesterman

Chief Financial Officer, Executive Vice President, Treasurer, Assistant Secretary

Kim Patrice Wolin

Executive Vice President - Operations, Secretary

Key Stats

2.00 mean rating - 1 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.0K

2017

0.0K

2018

0.0K

2019(E)

0.0K
EPS (USD)

2016

-1.710

2017

-1.120

2018

-0.630

2019(E)

-0.360
Price To Earnings (TTM)
--
Price To Sales (TTM)
95.28
Price To Book (MRQ)
6.17
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
8.41
LT Debt To Equity (MRQ)
4.99
Return on Investment (TTM)
-191.80
Return on Equity (TTM)
-155.52

Latest News

BRIEF-Senestech Inc Enters Termination Agreement With Neoventa Solutions​

* SENESTECH INC - ON FEB 7, ENTERED TERMINATION AGREEMENT WITH RESPECT TO AGREEMENT DATED SEPT 26, 2015 BETWEEN CO AND NEOVENTA SOLUTIONS

BRIEF-CVI Investments reports 7.9 percent passive stake in Senestech as of Nov 17

* CVI INVESTMENTS INC REPORTS A 7.9 PERCENT PASSIVE STAKE IN SENESTECH INC AS OF NOVEMBER 17, 2017 - SEC FILING Source text : [ID:http://bit.ly/2AEd4WC] Further company coverage:

BRIEF-Sabby Volatility Warrant Master Fund reports 7.92 pct passive stake in Senestech

* Sabby Volatility Warrant Master Fund reports 7.92 percent passive stake in Senestech as of November 17 - SEC filing Source text: (http://bit.ly/2jcuD51) Further company coverage:

BRIEF-SenesTech announces pricing of public offering of common stock and warrants to purchase common stock

* SenesTech announces pricing of public offering of common stock and warrants to purchase common stock

BRIEF-Senestech Inc files for offering up to 2.5 million shares of co's common stock

* Senestech Inc files for offering up to 2.5 million shares of co's common stock and warrants to purchase 625,000 shares of common stock Source text: (http://bit.ly/2m7wb52) Further company coverage:

BRIEF-SenesTech announces third quarter financial and operational results

* SenesTech announces third quarter financial and operational results

BRIEF-SenesTech signs a distribution agreement with Univar for ContraPest

* SenesTech signs a distribution agreement with Univar for ContraPest

BRIEF-SenesTech Q2 loss per share $0.35

* SenesTech announces second quarter financial and operational results

BRIEF-Senestech Inc announces sales agreement with an Arizona brewpub

* Senestech Inc - announced its latest sales agreement with an Arizona brewpub Source text for Eikon: Further company coverage:

BRIEF-Senestech - ‍confirmed reports that Chicago commencing new pilot program for controlling rodent populations utilizing co's product​, Contrapest

* Senestech - confirmed reports that city of Chicago commencing new pilot program for controlling rodent populations utilizing co's product, Contrapest Source text for Eikon: Further company coverage:

BRIEF-SenesTech signs two year agreement for ContraPest

* SenesTech signs two year agreement for ContraPest with animal sanctuary Wildhorse Ranch Rescue

BRIEF-SenesTech Q1 loss per share $0.34

* Q1 loss per share $0.34 Source text for Eikon: Further company coverage:

BRIEF-SenesTech and Neogen mutually agree to terminate Neogen Technology license

* SenesTech and Neogen mutually agree to terminate Neogen Technology license

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up